SCHEMBL22928199

SCHEMBL22928199

c1ccc2c(c1)-c1cc(-n3c4ccccc4c4ccccc43)ccc1C21c2ccccc2-c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
OPRK1 P41145 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DUSP3 P51452 1/20 0.35
PDK2 Q15119 8/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
GPR3 P46089 1/20 0.31
PTPN1 P18031 2/20 0.31
POLB P06746 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
ALDH1A1 P00352 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15087891 1.00 KDM4E (0.46) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL12685494 1.00 KDM4E (0.46) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL24667939 0.95 KDM4E (0.42) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL17854687 0.95 KDM4E (0.42) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL45670 0.95 KDM4E (0.42) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL17854692 0.95 KDM4E (0.42) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL17929438 0.93 KDM4E (0.40) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL13467821 0.92 KDM4E (0.44) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL21008867 0.92 KDM4E (0.44) KDM4EATML3MBTL1DUSP3PDK2
SCHEMBL24904676 0.92 KDM4E (0.44) KDM4EATML3MBTL1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 US disclosed
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 US disclosed
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS C1S, DRD1, DRD3 KDM4E 4589/4885ATM 2766/4885L3MBTL1 1207/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 KDM4E 4589/4885ATM 2766/4885L3MBTL1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.